NCT02483377

Brief Summary

This research trial studies how well patient navigation and tailored treatment planning work in Latina patients with breast cancer. Patient navigation and tailored treatment planning may provide extra support by guiding patients through the healthcare system, remove barriers to care and provide ease of access to essential resources, encourage patient participation in their care, provide in-language summaries and plans for follow-up care, improve patient access to needed supportive care services and may improve general healthcare experience in Latina patients with breast cancer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2015

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 26, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2017

Completed
Last Updated

April 20, 2017

Status Verified

April 1, 2017

Enrollment Period

1.9 years

First QC Date

June 24, 2015

Last Update Submit

April 18, 2017

Conditions

Keywords

Sign or Symptom

Outcome Measures

Primary Outcomes (5)

  • Number of missed appointments from the time of initial diagnosis to the completion of primary treatment (chemotherapy, surgery and radiation as applicable) as measured by CCCQ

    Questionnaire scores will be expressed as median values with 95% confidence intervals.

    Up to 12 months

  • Number of patients enrolled on clinical trials (interventional and non-interventional)

    Number of patients enrolled on clinical trials (interventional and non-interventional) will be quantified and compared to historical controls.

    Up to 12 months

  • Number of special referrals made

    Number of special referrals made (eg. social worker, genetic counseling, fertility) through the navigation system will quantified and compared to historical controls.

    Up to 12 months

  • Overall experience with breast cancer (broadly) and at LAC+USC as measured by experience-based questionnaire

    Up to 12 months

  • Usefulness, accessibility, and quality of the patient navigation model as measured by Continuity/Coordination of Care Questionnaire (CCCQ)

    Means and standard deviations will be summarized per outcome measures at 3, 6, and 12 months after baseline, and 95% confidence intervals for the difference in means will be calculated for each assessment time for total scores and subscale scores.

    Up to 12 months

Study Arms (1)

Observational (treatment summaries and plan report)

Patients receive treatment summaries and plan report that captures patient data through the use of an "intake checklist" completed during the initial consultation with the breast oncology team and used to guide referrals to existing services and programmed with generic information related to disease and treatment management plan. Additional elements, such as psycho-social services, exercise, and/or nutrition, identified by the patient self-report, will be incorporated. Patients also complete 3 questionnaires at each clinic visit.

Other: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Ancillary studies

Also known as: Quality of Life Assessment
Observational (treatment summaries and plan report)

Complete questionnaires

Observational (treatment summaries and plan report)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Self-identified Latina (or Hispanic) who is receiving ongoing care at LAC+USC Medical Center will be recruited.

You may qualify if:

  • Patients receiving ongoing care at LAC+USC
  • Self-identified as Latina (or Hispanic)
  • Known or suspected breast cancer
  • Being seen in a breast cancer high risk, screening or prevention program or clinic or in one of the breast cancer clinics (surgical or medical oncology)

You may not qualify if:

  • Inability to sign informed consent or complete questionnaires and forms
  • Self-identified as non-Latina (or non-Hispanic)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USC / Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States

Location

MeSH Terms

Conditions

Breast NeoplasmsSigns and Symptoms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, Signs and Symptoms

Study Officials

  • Heather Macdonald

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2015

First Posted

June 26, 2015

Study Start

March 5, 2015

Primary Completion

February 7, 2017

Study Completion

February 7, 2017

Last Updated

April 20, 2017

Record last verified: 2017-04

Locations